MIRA INFORM REPORT
|
Report No. : |
308175 |
|
Report Date : |
14.02.2015 |
IDENTIFICATION DETAILS
|
Name : |
VIRUPAKSHA ORGANICS LIMITED (w.e.f.13.01.2012) |
|
|
|
|
Formerly Known
As : |
VIRUPAKSHA ORGANICS PRIVATE LIMITED (22.06.2004) DRK CHEMICALS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Flat No.301, Preetham Residency, Plot No.1, Siddaratha Nagar,
Hyderabad – 500038, Telangana |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of Incorporation
: |
03.11.1997 |
|
|
|
|
Com. Reg. No.: |
036-028281 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 130.000 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24110TG1997PLC028281 |
|
|
|
|
IEC No.: |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Divulged |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCR0719B |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company. |
|
|
|
|
Line of Business
: |
Manufacturing of Bulk Drugs and Intermediates. |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 780000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track record. General financial position of the company is normal and acceptable for
business dealings. Trade relations are reported as fair. Business is active. Payment
terms are reported to be usually correct. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
India Rating |
|
Rating |
Long term Issuer rating (IND BBB-) |
|
Rating Explanation |
Moderate degree of safety it carry moderate credit risk. |
|
Date |
22.07.2014 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DECLINED
MANAGEMENT NON CO-OPERATIVE (91-40-23675816)
LOCATIONS
|
Registered Office : |
Flat No.301, Preetham Residency, Plot No.1, Siddaratha Nagar,
Hyderabad – 500038, Telangana, India |
|
Tel. No.: |
Not Available |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
Location : |
Owned |
|
|
|
|
Corporate Office : |
Flat No. B4, IDA, Gandhinagar, Balanagar, Hyderabad – 500037,
Telangana, India |
|
Tel. No.: |
91-40-23075816/ 23073079 |
|
Fax No.: |
91-40-23720736 |
|
|
|
|
Factory : |
Survey No. 10, Gaddareetharam Village, Jinnaram Mandal, Medak – 502230,
Andhra Pradesh, India |
DIRECTORS
As on 29.09.2014
|
Name : |
Chandra Mouliswar Reddy Gangavaram |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Managing director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
Flat No. 143, Siddartha Nagar, Behind Vengal Raonagar, Hyderabad –
500038, Telangana, India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
03.02.1963 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
Degree |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
21.06.2003 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00046845 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mamilla Bala Subba Reddy |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
F. No. 301, Preetham Residency, P.No.1, Siddartha Nagar, Hyderabad – 500038,
Telangana, India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
01.06.1964 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
Degree |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
03.11.1997 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
01998852 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship :
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2011
NOTE: SHAREHOLDING DETAILS FILE ATTACHED
As on 31.03.2012
NOTE: ALLOTTEES DETAILS FILE ATTACHED
As on 30.09.2011
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage |
|
Bodies corporate |
17.39 |
|
Directors or relatives of Directors |
82.61 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing of Bulk Drugs and Intermediates. |
|
|
|
|
Products : |
Not Available |
|
|
|
|
Brand Names : |
Not Divulged |
|
|
|
|
Agencies Held : |
Not Divulged |
|
|
|
|
Exports : |
Not Divulged |
|
|
|
|
Imports : |
Not Divulged |
|
|
|
|
Terms : |
Not Divulged |
GENERAL INFORMATION
|
Suppliers : |
Not Divulged |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
Not Divulged |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Not Divulged |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
-- |
|
|
|
|
Financial Institutions : |
· Reliance Capital Limited "H" Block 1st Floor, Dhirubhai Ambani Knowledge City, Koparkhairne, Navi Mumbai - 400710, Maharashtra, India · 3i Infotech Trusteeship Services Limited 3rd to 6th floor, International Infotech Park, Tower No.5,
Vashi Railway Station Complex, Vashi, Navi Mumbai - 400703, Maharashtra,
India |
|
|
|
|
Auditors : |
|
|
Name : |
Suryachandra and Associates Chartered Accountants |
|
Address : |
H. No. 8-3-315/8, Plot No. 10, Maruthi Nagar, Yousufuguda, Hyderabad,
Andhra Pradesh, India |
|
PAN No.: |
ABMPR9846E |
|
|
|
|
Memberships : |
Not Divulged |
|
|
|
|
Collaborators : |
Not Divulged |
|
|
|
|
Associates/Subsidiaries : |
Not Divulged |
CAPITAL STRUCTURE
As on 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
13000000 |
Equity Shares |
Rs. 10/- each |
Rs. 130.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
13000000 |
Equity Shares |
Rs. 10/- each |
Rs. 130.000 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
130.000 |
130.000 |
130.000 |
|
(b) Reserves & Surplus |
142.477 |
108.576 |
85.296 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
272.477 |
238.576 |
215.296 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
245.426 |
223.155 |
248.551 |
|
(b) Deferred tax liabilities (Net) |
40.233 |
36.942 |
34.494 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
0.000 |
0.000 |
0.000 |
|
Total Non-current
Liabilities (3) |
285.659 |
260.097 |
283.045 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
183.480 |
189.801 |
194.577 |
|
(b) Trade
payables |
370.814 |
361.437 |
257.558 |
|
(c) Other
current liabilities |
9.463 |
8.934 |
8.194 |
|
(d) Short-term
provisions |
10.440 |
6.435 |
3.822 |
|
Total Current
Liabilities (4) |
574.197 |
566.607 |
464.151 |
|
|
|
|
|
|
TOTAL |
1132.333 |
1065.280 |
962.492 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
415.147 |
416.669 |
417.262 |
|
(ii) Intangible
Assets |
0.000 |
0.000 |
0.000 |
|
(iii)
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
4.500 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
0.000 |
0.000 |
0.000 |
|
(e) Other
Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
419.647 |
416.669 |
417.262 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a) Current
investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
151.120 |
178.516 |
113.808 |
|
(c) Trade
receivables |
472.153 |
375.830 |
344.481 |
|
(d) Cash
and cash equivalents |
30.454 |
29.966 |
21.215 |
|
(e)
Short-term loans and advances |
22.168 |
29.608 |
29.480 |
|
(f) Other
current assets |
36.791 |
34.691 |
36.246 |
|
Total
Current Assets |
712.686 |
648.611 |
545.230 |
|
|
|
|
|
|
TOTAL |
1132.333 |
1065.280 |
962.492 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
1455.591 |
997.528 |
1083.589 |
|
|
|
Other Income |
12.395 |
29.097 |
1.209 |
|
|
|
TOTAL |
1467.986 |
1026.625 |
1084.798 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
963.065 |
727.201 |
814.912 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
37.725 |
(41.096) |
11.851 |
|
|
|
Employees benefits expense |
53.177 |
40.990 |
39.038 |
|
|
|
Other expenses |
277.495 |
191.272 |
118.800 |
|
|
|
TOTAL |
1331.462 |
918.367 |
984.601 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
136.524 |
108.258 |
100.197 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
58.612 |
49.154 |
56.071 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
77.912 |
59.104 |
44.126 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
29.782 |
26.943 |
25.022 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
48.130 |
32.161 |
19.104 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
14.229 |
8.882 |
9.751 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
33.901 |
23.279 |
9.353 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
295.226 |
245.364 |
218.676 |
|
|
TOTAL EARNINGS |
295.226 |
245.364 |
218.676 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
2.61 |
1.79 |
0.72 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin (PAT/Sales) |
(%) |
2.33 |
2.33 |
0.86 |
|
|
|
|
|
|
|
Operating Profit Margin (PBDIT / Sales) |
(%) |
9.38 |
10.85 |
9.25 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
4.27 |
3.02 |
1.98 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.18 |
0.13 |
0.09 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
1.57 |
1.73 |
2.06 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.24 |
1.14 |
1.17 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
130.000 |
130.000 |
130.000 |
|
Reserves & Surplus |
85.296 |
108.576 |
142.477 |
|
Net
worth |
215.296 |
238.576 |
272.477 |
|
|
|
|
|
|
long-term borrowings |
248.551 |
223.155 |
245.426 |
|
Short term borrowings |
194.577 |
189.801 |
183.480 |
|
Total
borrowings |
443.128 |
412.956 |
428.906 |
|
Debt/Equity
ratio |
2.058 |
1.731 |
1.574 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
1083.589 |
997.528 |
1455.591 |
|
|
|
(7.942) |
45.920 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
1083.589 |
997.528 |
1455.591 |
|
Profit |
9.353 |
23.279 |
33.901 |
|
|
0.86% |
2.33% |
2.33% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info
Agents |
Available in Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact person |
No |
|
11] |
Turnover of firm for last three years |
Yes |
|
12] |
Profitability for last three years |
Yes |
|
13] |
Reasons for variation <> 20% |
---------------------- |
|
14] |
Estimation for coming financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details (if applicable) |
No |
|
21] |
Market information |
---------------------- |
|
22] |
Litigations that the firm / promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
No |
|
25] |
Conduct of the banking account |
---------------------- |
|
26] |
Buyer visit details |
---------------------- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if applicable |
Yes |
|
29] |
Last accounts filed at ROC |
Yes |
|
30] |
Major Shareholders, if available |
Yes |
|
31] |
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating, if available |
No |
INDEX OF CHARGES
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10500564 |
14/05/2014 |
2,516,864.00 |
RELIANCE CAPITAL
LTD |
"H" BLOCK 1ST FLOOR, Dhirubhai
Ambani Knowledge City, Koparkhairne, Navi Mumbai, Maharashtra - 4007 |
C05374434 |
|
2 |
10456887 |
25/09/2013 |
4,300,000.00 |
RELIANCE CAPITAL
LTD |
"H" BLOCK 1ST FLOOR, Dhirubhai Ambani
Knowledge City, Koparkhairne, Navi Mumbai, Maharashtra - 4007 |
B88225446 |
|
3 |
10410281 |
21/02/2013 |
2,100,000.00 |
RELIANCE CAPITAL
LTD |
"H" BLOCK 1ST FLOOR, Dhirubhai Ambani
Knowledge City, Koparkhairne, Navi Mumbai, Maharashtra - 4007 |
B70252838 |
|
4 |
10342379 |
31/01/2012 |
4,400,000.00 |
RELIANCE CAPITAL
LTD |
"H" BLOCK 1ST FLOOR, Dhirubhai Ambani
Knowledge City, Koparkhairne, Navi Mumbai, Maharashtra - 4007 |
B35094341 |
|
5 |
10030339 |
17/09/2011 * |
429,800,000.00 |
STATE BANK OF
INDIA |
SAIFABAD (SIB) BRANCH,, HACA BHAVAN, OPP :
ASSEMB |
B24369589 |
* Date of charge modification
OPERATIONS:
The sales and other
income for the year increased to 1601.077 Millions from Rs. 1113.311 Millions with
an increase of 43.81%. Export sales was increased to 344.809 Millions from
259.395 Millions with an increase of 32.93%. The company could achieve the
higher turnover due to increase in demand for the products like Fluconazole,
Fexo Phenadine and Tramadol. The quality of our products has been well accepted
by the market and getting good orders from reputed companies like M/s. Refermed
Chemicals Private Limited, Glenmark Pharmaceutical Limited, Dr. Reddy’s
Laboratories Limited, Symed Lab Limited, Cadila Healthcare Limited, Cipla
Limited, and M/s. Ranbaxy Laboratories Limited.
The company is
fully concentrating on regulatory markets like Japan, USA & Europe. The
company has already got Japan FDA approval for Fluconazole and business has
started from Japan.
The company has got
certificate of Suitability (COS) from European authority’s i.e. EDQM for Fexo
Fenadine HCL and Fluconazole. Your company already submitted drug master files
(DMF) for Tramadol also in both USA and Europe.
The company happy
to inform you that we have got USFDA approved for our plant, and your company
has got approval from Mexico for all our products. And the company has also got
approval from South Korea for Tramadol.
The company happy
to inform you that one of the top company in USA has triggered our product
Fexofenadine for US market and Flucanazole also to USA market, our product
Fluconazole has got approval from china SFDA, and expected Fexo also.
The company is
fully concentrating in development of new products which has good market both
in domestic and export.
The company is
expecting good business from regulatory market for Fexofenadine and Fluconazole
in 2014-15.
The company is also
concentrating on development of advanced intermediates for New APIs, and the
company is entering in sum reputed multi-national companies (MNC’s) of the
India and Foreign companies. They got turnover Rs. 80.000 Millions from the new
Intermediates, the business may increase considerably and expecting good
turnover in 2014-15 and 2015-16.
FIXED ASSETS
· Land
· Buildings
· Plant and Equipment
· Furniture and Fixtures
· Vehicles
· Office Equipment
· Computer Equipments
· Other Equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources including
but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist organization
or whom notice had been received that all financial transactions involving
their assets have been blocked or convicted, found guilty or against whom a
judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record exists
to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 61.50 |
|
|
1 |
Rs. 93.12 |
|
Euro |
1 |
Rs. 69.33 |
INFORMATION DETAILS
|
Information
Gathered by : |
PRT |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
4 |
|
--CREDIT LINES |
1~10 |
4 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER
|
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.